Global Liquid Biopsy Products Market Size, Share, Trends and Forecast 2022-2030

Description

Market Analysis and Insights: Global Liquid Biopsy Products Market
The research report studies the Liquid Biopsy Products market using different methodologies and analyzes to provide accurate and in-depth information about the market. For a clearer understanding, it is divided into several parts to cover different aspects of the market. Each area is then elaborated to help the reader comprehend the growth potential of each region and its contribution to the global market. The researchers have used primary and secondary methodologies to collate the information in the report. They have also used the same data to generate the current market scenario. This report is aimed at guiding people towards an apprehensive, better, and clearer knowledge of the market.
The global Liquid Biopsy Products market size is projected to reach US$ 6696.9 million by 2027, from US$ 1391 million in 2020, at a CAGR of 25.5% during 2021-2027.
Global Liquid Biopsy Products Scope and Segment
The global Liquid Biopsy Products market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Liquid Biopsy Products market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type, and by Application for the period 2016-2027.
by Type, the market is primarily split into
CTCs
ctDNA
Exosomes
by Application, this report covers the following segments
Blood Sample
Urine Sample
Other Bio Fluids
Global Liquid Biopsy Products market: regional analysis, the major regions covered in the report are:
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia-Pacific
Latin America
Mexico
Brazil
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of Middle East & Africa
The report lists the major players in the regions and their respective market share on the basis of global revenue. It also explains their strategic moves in the past few years, investments in product innovation, and changes in leadership to stay ahead in the competition. This will give the reader an edge over others as a well-informed decision can be made looking at the holistic picture of the market.
The Liquid Biopsy Products key players in this market include:
RainDanceTechnologies
Biocartis
Qiagen
Guardant Health
MDxHealth
Pathway Genomics
NeoGenomics Laboraories
Sysmex Inostics
Cynvenio
Menarini Silicon Biosystems
Adaptive Biotechnologies
Biocept
Angle plc

TABLE OF CONTENT

1 Market Overview of Liquid Biopsy Products
1.1 Liquid Biopsy Products Market Overview
1.1.1 Liquid Biopsy Products Product Scope
1.1.2 Liquid Biopsy Products Market Status and Outlook
1.2 Global Liquid Biopsy Products Market Size Overview by Region 2016 VS 2030VS 2027
1.3 Global Liquid Biopsy Products Market Size by Region (2016-2027)
1.4 Global Liquid Biopsy Products Historic Market Size by Region (2016-2030)
1.5 Global Liquid Biopsy Products Market Size Forecast by Region (2022-2027)
1.6 Key Regions, Liquid Biopsy Products Market Size (2016-2027)
1.6.1 North America Liquid Biopsy Products Market Size (2016-2027)
1.6.2 Europe Liquid Biopsy Products Market Size (2016-2027)
1.6.3 Asia-Pacific Liquid Biopsy Products Market Size (2016-2027)
1.6.4 Latin America Liquid Biopsy Products Market Size (2016-2027)
1.6.5 Middle East & Africa Liquid Biopsy Products Market Size (2016-2027)

2 Liquid Biopsy Products Market Overview by Type
2.1 Global Liquid Biopsy Products Market Size by Type: 2016 VS 2030 VS 2027
2.2 Global Liquid Biopsy Products Historic Market Size by Type (2016-2030)
2.3 Global Liquid Biopsy Products Forecasted Market Size by Type (2022-2027)
2.4 CTCs
2.5 ctDNA
2.6 Exosomes

3 Liquid Biopsy Products Market Overview by Application
3.1 Global Liquid Biopsy Products Market Size by Application: 2016 VS 2030 VS 2027
3.2 Global Liquid Biopsy Products Historic Market Size by Application (2016-2030)
3.3 Global Liquid Biopsy Products Forecasted Market Size by Application (2022-2027)
3.4 Blood Sample
3.5 Urine Sample
3.6 Other Bio Fluids

4 Liquid Biopsy Products Competition Analysis by Players
4.1 Global Liquid Biopsy Products Market Size by Players (2016-2030)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Liquid Biopsy Products as of 2020)
4.3 Date of Key Players Enter into Liquid Biopsy Products Market
4.4 Global Top Players Liquid Biopsy Products Headquarters and Area Served
4.5 Key Players Liquid Biopsy Products Product Solution and Service
4.6 Competitive Status
4.6.1 Liquid Biopsy Products Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans

5 Company (Top Players) Profiles and Key Data
5.1 RainDanceTechnologies
5.1.1 RainDanceTechnologies Profile
5.1.2 RainDanceTechnologies Main Business
5.1.3 RainDanceTechnologies Liquid Biopsy Products Products, Services and Solutions
5.1.4 RainDanceTechnologies Liquid Biopsy Products Revenue (US$ Million) & (2016-2030)
5.1.5 RainDanceTechnologies Recent Developments
5.2 Biocartis
5.2.1 Biocartis Profile
5.2.2 Biocartis Main Business
5.2.3 Biocartis Liquid Biopsy Products Products, Services and Solutions
5.2.4 Biocartis Liquid Biopsy Products Revenue (US$ Million) & (2016-2030)
5.2.5 Biocartis Recent Developments
5.3 Qiagen
5.3.1 Qiagen Profile
5.3.2 Qiagen Main Business
5.3.3 Qiagen Liquid Biopsy Products Products, Services and Solutions
5.3.4 Qiagen Liquid Biopsy Products Revenue (US$ Million) & (2016-2030)
5.3.5 Guardant Health Recent Developments
5.4 Guardant Health
5.4.1 Guardant Health Profile
5.4.2 Guardant Health Main Business
5.4.3 Guardant Health Liquid Biopsy Products Products, Services and Solutions
5.4.4 Guardant Health Liquid Biopsy Products Revenue (US$ Million) & (2016-2030)
5.4.5 Guardant Health Recent Developments
5.5 MDxHealth
5.5.1 MDxHealth Profile
5.5.2 MDxHealth Main Business
5.5.3 MDxHealth Liquid Biopsy Products Products, Services and Solutions
5.5.4 MDxHealth Liquid Biopsy Products Revenue (US$ Million) & (2016-2030)
5.5.5 MDxHealth Recent Developments
5.6 Pathway Genomics
5.6.1 Pathway Genomics Profile
5.6.2 Pathway Genomics Main Business
5.6.3 Pathway Genomics Liquid Biopsy Products Products, Services and Solutions
5.6.4 Pathway Genomics Liquid Biopsy Products Revenue (US$ Million) & (2016-2030)
5.6.5 Pathway Genomics Recent Developments
5.7 NeoGenomics Laboraories
5.7.1 NeoGenomics Laboraories Profile
5.7.2 NeoGenomics Laboraories Main Business
5.7.3 NeoGenomics Laboraories Liquid Biopsy Products Products, Services and Solutions
5.7.4 NeoGenomics Laboraories Liquid Biopsy Products Revenue (US$ Million) & (2016-2030)
5.7.5 NeoGenomics Laboraories Recent Developments
5.8 Sysmex Inostics
5.8.1 Sysmex Inostics Profile
5.8.2 Sysmex Inostics Main Business
5.8.3 Sysmex Inostics Liquid Biopsy Products Products, Services and Solutions
5.8.4 Sysmex Inostics Liquid Biopsy Products Revenue (US$ Million) & (2016-2030)
5.8.5 Sysmex Inostics Recent Developments
5.9 Cynvenio
5.9.1 Cynvenio Profile
5.9.2 Cynvenio Main Business
5.9.3 Cynvenio Liquid Biopsy Products Products, Services and Solutions
5.9.4 Cynvenio Liquid Biopsy Products Revenue (US$ Million) & (2016-2030)
5.9.5 Cynvenio Recent Developments
5.10 Menarini Silicon Biosystems
5.10.1 Menarini Silicon Biosystems Profile
5.10.2 Menarini Silicon Biosystems Main Business
5.10.3 Menarini Silicon Biosystems Liquid Biopsy Products Products, Services and Solutions
5.10.4 Menarini Silicon Biosystems Liquid Biopsy Products Revenue (US$ Million) & (2016-2030)
5.10.5 Menarini Silicon Biosystems Recent Developments
5.11 Adaptive Biotechnologies
5.11.1 Adaptive Biotechnologies Profile
5.11.2 Adaptive Biotechnologies Main Business
5.11.3 Adaptive Biotechnologies Liquid Biopsy Products Products, Services and Solutions
5.11.4 Adaptive Biotechnologies Liquid Biopsy Products Revenue (US$ Million) & (2016-2030)
5.11.5 Adaptive Biotechnologies Recent Developments
5.12 Biocept
5.12.1 Biocept Profile
5.12.2 Biocept Main Business
5.12.3 Biocept Liquid Biopsy Products Products, Services and Solutions
5.12.4 Biocept Liquid Biopsy Products Revenue (US$ Million) & (2016-2030)
5.12.5 Biocept Recent Developments
5.13 Angle plc
5.13.1 Angle plc Profile
5.13.2 Angle plc Main Business
5.13.3 Angle plc Liquid Biopsy Products Products, Services and Solutions
5.13.4 Angle plc Liquid Biopsy Products Revenue (US$ Million) & (2016-2030)
5.13.5 Angle plc Recent Developments

6 North America
6.1 North America Liquid Biopsy Products Market Size by Country (2016-2027)
6.2 United States
6.3 Canada

7 Europe
7.1 Europe Liquid Biopsy Products Market Size by Country (2016-2027)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic
7.8 Rest of Europe

8 Asia-Pacific
8.1 Asia-Pacific Liquid Biopsy Products Market Size by Region (2016-2027)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific

9 Latin America
9.1 Latin America Liquid Biopsy Products Market Size by Country (2016-2027)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America

10 Middle East & Africa
10.1 Middle East & Africa Liquid Biopsy Products Market Size by Country (2016-2027)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa

11 Liquid Biopsy Products Market Dynamics
11.1 Liquid Biopsy Products Industry Trends
11.2 Liquid Biopsy Products Market Drivers
11.3 Liquid Biopsy Products Market Challenges
11.4 Liquid Biopsy Products Market Restraints

12 Research Finding /Conclusion

13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List

Choose License Type

Checkout Inquiry Sample